Introducing high-throughput sequencing into mainstream genetic diagnosis practice in inherited platelet disordersJosé María Bastida, José Ramón González‐Porras, Teresa Sevivas et al.|Haematologica|2017Cited by 124
Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONYLarry Mansouri, María José Terol, Birna Þorvaldsdóttir et al.|Leukemia|2022Cited by 55
Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemiaMaribel Forero‐Castro, Jesús María Hernández‐Rivas, Cristina Robledo et al.|British Journal of Cancer|2017Cited by 51
ATM aberrations in chronic lymphocytic leukemia: del(11q) rather than ATM mutations is an adverse-prognostic biomarkerBirna Þorvaldsdóttir, Richard Rosenquist, Larry Mansouri et al.|Leukemia|2025Cited by 5
Different Prognostic Impact of Recurrent Gene Mutations in IGHV-Mutated and IGHV-Unmutated Chronic Lymphocytic Leukemia: A Retrospective, Multi-Center Cohort Study By Eric, the European Research Initiative on CLL, in HarmonyLarry Mansouri, Šárka Pospı́šilová, Birna Þorvaldsdóttir et al.|Blood|2021Cited by 2